Stock XBIO XENETIC BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Xenetic Biosciences, Inc.

Equities

XBIO

US9840156023

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
4.46 USD +11.08% Intraday chart for Xenetic Biosciences, Inc. +15.55% +29.27%
05-22 Xenetic Biosciences, Inc. Announces Management Resignations CI
05-22 Xenetic Biosciences, Inc. Announces Chief Executive Officer Changes CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Xenetic Biosciences : Announces Executive Leadership Transition - Form 8-K
PU
Xenetic Biosciences, Inc. Announces Management Resignations
CI
Xenetic Biosciences, Inc. Announces Chief Executive Officer Changes
CI
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
AQ
Xenetic Biosciences : Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K
PU
Xenetic Biosciences: Q1 Earnings Snapshot
AQ
Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
AQ
Xenetic Biosciences : Reports Full Year 2023 Financial Results - Form 8-K
PU
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CLS Therapeutics Discloses its Views on Xenetic Biosciences
CI
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of Its DNase-Based Oncology Platform
CI
Xenetic Biosciences: Q3 Earnings Snapshot
AQ
Xenetic Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference
AQ
Xenetic Biosciences: Q2 Earnings Snapshot
AQ
Xenetic Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
North American Morning Briefing : Debt-Ceiling -2-
DJ
HC Wainwright Downgrades Xenetic Biosciences to Neutral From Buy
MT
Xenetic Biosciences to Implement 1-for-10 Reverse Split
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XBIO Stock
  4. News Xenetic Biosciences, Inc.